EG21755A - Process for preparing of lercanidipine hydrochloride and their use for the treatment of angina and coronary disease - Google Patents
Process for preparing of lercanidipine hydrochloride and their use for the treatment of angina and coronary diseaseInfo
- Publication number
- EG21755A EG21755A EG40296A EG40296A EG21755A EG 21755 A EG21755 A EG 21755A EG 40296 A EG40296 A EG 40296A EG 40296 A EG40296 A EG 40296A EG 21755 A EG21755 A EG 21755A
- Authority
- EG
- Egypt
- Prior art keywords
- angina
- preparing
- treatment
- coronary disease
- lercanidipine hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI950957A IT1274480B (it) | 1995-05-12 | 1995-05-12 | Procedimento migliorato per la preparazione della lercanidipina cloridrato |
Publications (1)
Publication Number | Publication Date |
---|---|
EG21755A true EG21755A (en) | 2002-02-27 |
Family
ID=11371581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG40296A EG21755A (en) | 1995-05-12 | 1996-05-09 | Process for preparing of lercanidipine hydrochloride and their use for the treatment of angina and coronary disease |
Country Status (37)
Country | Link |
---|---|
EP (1) | EP0824517B1 (xx) |
JP (1) | JP4038622B2 (xx) |
KR (1) | KR100395441B1 (xx) |
CN (1) | CN1101810C (xx) |
AR (1) | AR002739A1 (xx) |
AT (1) | ATE221050T1 (xx) |
AU (1) | AU694046B2 (xx) |
BG (1) | BG62400B1 (xx) |
BR (1) | BR9608374A (xx) |
CA (1) | CA2217849C (xx) |
CZ (1) | CZ288634B6 (xx) |
DE (1) | DE69622552T2 (xx) |
DK (1) | DK0824517T3 (xx) |
DZ (1) | DZ2032A1 (xx) |
EA (1) | EA000346B1 (xx) |
EE (1) | EE03351B1 (xx) |
EG (1) | EG21755A (xx) |
ES (1) | ES2179942T3 (xx) |
HU (1) | HU226709B1 (xx) |
IL (1) | IL118143A (xx) |
IN (1) | IN188486B (xx) |
IT (1) | IT1274480B (xx) |
MA (1) | MA23858A1 (xx) |
MX (1) | MX9708662A (xx) |
MY (1) | MY113802A (xx) |
NO (1) | NO309423B1 (xx) |
NZ (1) | NZ309059A (xx) |
PL (1) | PL185260B1 (xx) |
PT (1) | PT824517E (xx) |
RO (1) | RO119616B1 (xx) |
SA (1) | SA96170216B1 (xx) |
SK (1) | SK283321B6 (xx) |
TN (1) | TNSN96069A1 (xx) |
TW (1) | TW404940B (xx) |
UA (1) | UA46769C2 (xx) |
WO (1) | WO1996035668A1 (xx) |
ZA (1) | ZA963716B (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6852737B2 (en) | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
ITMI20011726A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
EP1553941A1 (en) * | 2002-10-16 | 2005-07-20 | Recordati Ireland Limited | Lisinopril/lercanidipine combination therapy |
AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
KR100713136B1 (ko) * | 2005-05-04 | 2007-05-02 | 주식회사 대희화학 | 무수 레르카니디핀 염화수소 결정다형의 개선된 신규결정화 방법 |
ES2335026T3 (es) | 2005-06-15 | 2010-03-18 | Hetero Drugs Limited | Nuevo procedimiento de preparacion de lercanipidina. |
WO2007031865A2 (en) | 2005-09-16 | 2007-03-22 | Glenmark Pharmaceuticals Limited | Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
KR100811497B1 (ko) * | 2005-10-19 | 2008-03-07 | 신풍제약주식회사 | 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법 |
EP1860102B1 (en) * | 2006-05-24 | 2008-11-26 | CF Pharma Ltd. | Process for Producing Lercanidipine |
KR100808281B1 (ko) * | 2006-06-30 | 2008-03-03 | 주식회사 하원정밀화학 | 레르카니디핀 및 그 산부가염의 제조방법 |
CN102020602B (zh) * | 2009-09-18 | 2013-12-25 | 深圳信立泰药业股份有限公司 | 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物 |
WO2011161223A2 (en) | 2010-06-23 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
EP2654729B1 (en) | 2010-12-24 | 2016-05-04 | KRKA, d.d., Novo mesto | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid |
CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
CN102516160B (zh) * | 2011-12-16 | 2014-04-02 | 华润赛科药业有限责任公司 | 一种高纯盐酸乐卡地平的合成工艺 |
CN102584682A (zh) * | 2011-12-31 | 2012-07-18 | 苏州二叶制药有限公司 | 盐酸乐卡地平的制备方法 |
CN109956943B (zh) * | 2019-04-18 | 2021-07-20 | 合肥合源药业有限公司 | 一种二氢吡啶类药物中脱羧缩合杂质及其制备、控制方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
-
1995
- 1995-05-12 IT ITMI950957A patent/IT1274480B/it active IP Right Grant
-
1996
- 1996-05-03 IL IL11814396A patent/IL118143A/en not_active IP Right Cessation
- 1996-05-06 IN IN822CA1996 patent/IN188486B/en unknown
- 1996-05-07 MA MA24223A patent/MA23858A1/fr unknown
- 1996-05-08 DZ DZ960075A patent/DZ2032A1/fr active
- 1996-05-09 HU HU9801913A patent/HU226709B1/hu unknown
- 1996-05-09 JP JP53379796A patent/JP4038622B2/ja not_active Expired - Lifetime
- 1996-05-09 DK DK96916111T patent/DK0824517T3/da active
- 1996-05-09 RO RO97-02101A patent/RO119616B1/ro unknown
- 1996-05-09 EE EE9700303A patent/EE03351B1/xx unknown
- 1996-05-09 SK SK1514-97A patent/SK283321B6/sk not_active IP Right Cessation
- 1996-05-09 CZ CZ19973567A patent/CZ288634B6/cs not_active IP Right Cessation
- 1996-05-09 AT AT96916111T patent/ATE221050T1/de active
- 1996-05-09 NZ NZ309059A patent/NZ309059A/xx not_active IP Right Cessation
- 1996-05-09 EP EP96916111A patent/EP0824517B1/en not_active Expired - Lifetime
- 1996-05-09 WO PCT/EP1996/002122 patent/WO1996035668A1/en active IP Right Grant
- 1996-05-09 BR BR9608374A patent/BR9608374A/pt not_active Application Discontinuation
- 1996-05-09 MY MYPI96001751A patent/MY113802A/en unknown
- 1996-05-09 ES ES96916111T patent/ES2179942T3/es not_active Expired - Lifetime
- 1996-05-09 CN CN96193842A patent/CN1101810C/zh not_active Expired - Lifetime
- 1996-05-09 PL PL96323236A patent/PL185260B1/pl unknown
- 1996-05-09 CA CA002217849A patent/CA2217849C/en not_active Expired - Lifetime
- 1996-05-09 EG EG40296A patent/EG21755A/xx active
- 1996-05-09 AU AU58985/96A patent/AU694046B2/en not_active Expired
- 1996-05-09 KR KR1019970707905A patent/KR100395441B1/ko not_active IP Right Cessation
- 1996-05-09 PT PT96916111T patent/PT824517E/pt unknown
- 1996-05-09 EA EA199700374A patent/EA000346B1/ru not_active IP Right Cessation
- 1996-05-09 DE DE69622552T patent/DE69622552T2/de not_active Expired - Lifetime
- 1996-05-09 UA UA97125981A patent/UA46769C2/uk unknown
- 1996-05-10 TW TW085105567A patent/TW404940B/zh not_active IP Right Cessation
- 1996-05-10 TN TNTNSN96069A patent/TNSN96069A1/fr unknown
- 1996-05-10 ZA ZA963716A patent/ZA963716B/xx unknown
- 1996-05-10 AR ARP960102528A patent/AR002739A1/es unknown
- 1996-08-07 SA SA96170216A patent/SA96170216B1/ar unknown
-
1997
- 1997-11-07 BG BG102034A patent/BG62400B1/bg unknown
- 1997-11-11 MX MX9708662A patent/MX9708662A/es unknown
- 1997-11-11 NO NO975176A patent/NO309423B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG21755A (en) | Process for preparing of lercanidipine hydrochloride and their use for the treatment of angina and coronary disease | |
HUP9600255A1 (en) | Various forms of paroxetin hydrochloride and process for their preparation | |
NO962179D0 (no) | Fremgangsmåte for fremstilling av metallocen og anvendelse derav | |
HUP9801836A3 (en) | Guanine derivative and process for producing thereof | |
HUP9603112A2 (en) | New pharmaceutical formulation and process for its production | |
HU9603484D0 (en) | Pharmaceutical compositions and process for producing symptom-transduction | |
HU9600596D0 (en) | Method of treating cardiac in flammatory disease | |
HUP9801697A3 (en) | Modified mp52-protein and process for producing thereof | |
IL124473A0 (en) | Therapeutic garments for scars and a process for the preparation thereof | |
HUP9900947A3 (en) | Process for the preparation of piperidine derivatives, intermediates and preparation thereof | |
HU9402832D0 (en) | Imidazol-4-yl-piperidine derivatives, process for producing them and pharmaceutical use of them | |
EP0761718A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
HU9600624D0 (en) | Piperidine derivatives, process for producing them and their pharmaceutical use | |
EP0837626A4 (en) | NAIL AND ITS FORGING METHOD | |
EP0722949A3 (en) | Process for the preparation of cyclopentadienyl compounds and compounds produced by the process | |
HU9502503D0 (en) | 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical use of them | |
DE69615316D1 (de) | Keramischer Wabenkörper und Verfahren zu dessen Herstellung | |
EP0761721A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
HK1016180A1 (en) | Process for the preparation of anti-malarial drugs | |
EP0761719A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
HU9503782D0 (en) | 1-oxo-2-(phenyl-sulfonyl-amino)-pentyl-piperidine derivatives, process for producing them and pharmaceutical use of them | |
SG44059A1 (en) | Process for preparing acetoxyazetidinone derivative and intermediate thereof | |
EP0761720A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
NO971419L (no) | Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder | |
IL117191A0 (en) | Process for the preparation of oxazolidinones and their use |